InvestorsHub Logo

orangecat

11/12/18 5:07 PM

#940 RE: Lenard #939

There are huge uncertainties investing in any small biotech. If you are a trader that was hoping for a big pop on FDA approval the price action was a huge bummer. I am long and have some 2019 calls also, but I too thought there would be a pop on approval and picked up some Nov. calls. I suspect there is about a 98% chance they worthless. That sucks, but I still feel good about my long term investment.